Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$56.2M Buy
2,309,944
+521,591
+29% +$12.2M 0.04% 463
2014
Q2
$46.5M Sell
1,788,353
-104,759
-6% -$2.67M 0.04% 481
2014
Q1
$45.3M Buy
1,893,112
+561,668
+42% +$11.8M 0.04% 432
2013
Q4
$26M Sell
1,331,444
-166,576
-11% -$3.35M 0.02% 662
2013
Q3
$31.7M Buy
1,498,020
+178,214
+14% +$3.9M 0.03% 508
2013
Q2
$29.1M Buy
+1,319,806
New +$32M 0.03% 489

Other funds holding EXC

UBS's EXC Position: Q3 2014 in Review

UBS increased its Exelon (EXC) stake by 29% in Q3 2014, buying an estimated $12.2M and bringing the position to 2,309,944 shares worth $56.2M. The position accounts for 0.04% of the portfolio, ranked #463.

UBS first reported a position in EXC in Q2 2013 and has held it in 6 quarters since. 701 funds tracked by Wall St. Rank hold EXC as of Q3 2014.

  • UBS held 2,309,944 shares of Exelon worth $56.2M as of Q3 2014.
  • UBS bought 521,591 Exelon shares in Q3 2014, an estimated $12.2M.
  • Exelon made up 0.04% of UBS's portfolio in Q3 2014, its #463 holding.
  • UBS first reported a position in Exelon in Q2 2013 and has held it in 6 quarters since.
  • 701 funds tracked by Wall St. Rank held Exelon as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.